胃癌薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Gastric Cancer Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03891 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、胃癌薬の世界市場について調査・分析し、胃癌薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ドキソルビシン塩酸塩、スニチニブ、ドセタキセル、マイトマイシン、フルオロウラシル、イマチニブ、トラスツズマブ）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胃癌薬市場動向 ・主要企業別マーケットシェア ・胃癌薬の種類別市場規模2014-2019 （ドキソルビシン塩酸塩、スニチニブ、ドセタキセル、マイトマイシン、フルオロウラシル、イマチニブ、トラスツズマブ） ・胃癌薬の用途別市場規模2014-2019 （病院、診療所、その他） ・胃癌薬の北米市場：主要企業・種類別/用途別市場規模 ・胃癌薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・胃癌薬の中国市場：主要企業・種類別/用途別市場規模 ・胃癌薬の日本国内市場：主要企業・種類別/用途別市場規模 ・胃癌薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・胃癌薬のインド市場：主要企業・種類別/用途別市場規模 ・胃癌薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Sanofi、Eli Lilly、F. Hoffmann-La Roche、Otsuka Pharmaceutical、Novartis、Amgen、Merck、AstraZeneca、Boehringer Ingelheim、Daiichi-Sankyo、Bayer HealthCare） ・胃癌薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Gastric cancer drugs are used to treat malignancies, or cancerous growths.The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive market share of nearly 45% during the forecast period.
The world gastric cancer drugs market could be classified into seven types: doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab.
In 2018, the global Gastric Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gastric Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastric Cancer Drugs development in United States, Europe and China.

The key players covered in this study
Sanofi
Eli Lilly
F. Hoffmann-La Roche
Otsuka Pharmaceutical
Novartis
Amgen
Merck
AstraZeneca
Boehringer Ingelheim
Daiichi-Sankyo
Bayer HealthCare

Market segment by Type, the product can be split into
Doxorubicin Hydrochloride
Sunitinib
Docetaxel
Mitomycin
Fluorouracil
Imatinib
Trastuzumab

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gastric Cancer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Gastric Cancer Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gastric Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastric Cancer Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Doxorubicin Hydrochloride
1.4.3 Sunitinib
1.4.4 Docetaxel
1.4.5 Mitomycin
1.4.6 Fluorouracil
1.4.7 Imatinib
1.4.8 Trastuzumab
1.5 Market by Application
1.5.1 Global Gastric Cancer Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gastric Cancer Drugs Market Size
2.2 Gastric Cancer Drugs Growth Trends by Regions
2.2.1 Gastric Cancer Drugs Market Size by Regions (2014-2025)
2.2.2 Gastric Cancer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gastric Cancer Drugs Market Size by Manufacturers
3.1.1 Global Gastric Cancer Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Gastric Cancer Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gastric Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Gastric Cancer Drugs Key Players Head office and Area Served
3.3 Key Players Gastric Cancer Drugs Product/Solution/Service
3.4 Date of Enter into Gastric Cancer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gastric Cancer Drugs Market Size by Type (2014-2019)
4.2 Global Gastric Cancer Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Gastric Cancer Drugs Market Size (2014-2019)
5.2 Gastric Cancer Drugs Key Players in United States
5.3 United States Gastric Cancer Drugs Market Size by Type
5.4 United States Gastric Cancer Drugs Market Size by Application

6 Europe
6.1 Europe Gastric Cancer Drugs Market Size (2014-2019)
6.2 Gastric Cancer Drugs Key Players in Europe
6.3 Europe Gastric Cancer Drugs Market Size by Type
6.4 Europe Gastric Cancer Drugs Market Size by Application

7 China
7.1 China Gastric Cancer Drugs Market Size (2014-2019)
7.2 Gastric Cancer Drugs Key Players in China
7.3 China Gastric Cancer Drugs Market Size by Type
7.4 China Gastric Cancer Drugs Market Size by Application

8 Japan
8.1 Japan Gastric Cancer Drugs Market Size (2014-2019)
8.2 Gastric Cancer Drugs Key Players in Japan
8.3 Japan Gastric Cancer Drugs Market Size by Type
8.4 Japan Gastric Cancer Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gastric Cancer Drugs Market Size (2014-2019)
9.2 Gastric Cancer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Gastric Cancer Drugs Market Size by Type
9.4 Southeast Asia Gastric Cancer Drugs Market Size by Application

10 India
10.1 India Gastric Cancer Drugs Market Size (2014-2019)
10.2 Gastric Cancer Drugs Key Players in India
10.3 India Gastric Cancer Drugs Market Size by Type
10.4 India Gastric Cancer Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Gastric Cancer Drugs Market Size (2014-2019)
11.2 Gastric Cancer Drugs Key Players in Central & South America
11.3 Central & South America Gastric Cancer Drugs Market Size by Type
11.4 Central & South America Gastric Cancer Drugs Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastric Cancer Drugs Introduction
12.1.4 Sanofi Revenue in Gastric Cancer Drugs Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastric Cancer Drugs Introduction
12.2.4 Eli Lilly Revenue in Gastric Cancer Drugs Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 F. Hoffmann-La Roche
12.3.1 F. Hoffmann-La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastric Cancer Drugs Introduction
12.3.4 F. Hoffmann-La Roche Revenue in Gastric Cancer Drugs Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Recent Development
12.4 Otsuka Pharmaceutical
12.4.1 Otsuka Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastric Cancer Drugs Introduction
12.4.4 Otsuka Pharmaceutical Revenue in Gastric Cancer Drugs Business (2014-2019)
12.4.5 Otsuka Pharmaceutical Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastric Cancer Drugs Introduction
12.5.4 Novartis Revenue in Gastric Cancer Drugs Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gastric Cancer Drugs Introduction
12.6.4 Amgen Revenue in Gastric Cancer Drugs Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gastric Cancer Drugs Introduction
12.7.4 Merck Revenue in Gastric Cancer Drugs Business (2014-2019)
12.7.5 Merck Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gastric Cancer Drugs Introduction
12.8.4 AstraZeneca Revenue in Gastric Cancer Drugs Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gastric Cancer Drugs Introduction
12.9.4 Boehringer Ingelheim Revenue in Gastric Cancer Drugs Business (2014-2019)
12.9.5 Boehringer Ingelheim Recent Development
12.10 Daiichi-Sankyo
12.10.1 Daiichi-Sankyo Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gastric Cancer Drugs Introduction
12.10.4 Daiichi-Sankyo Revenue in Gastric Cancer Drugs Business (2014-2019)
12.10.5 Daiichi-Sankyo Recent Development
12.11 Bayer HealthCare

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Gastric Cancer Drugs Key Market Segments
Table Key Players Gastric Cancer Drugs Covered
Table Global Gastric Cancer Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gastric Cancer Drugs Market Size Market Share by Type 2014-2025
Figure Doxorubicin Hydrochloride Figures
Table Key Players of Doxorubicin Hydrochloride
Figure Sunitinib Figures
Table Key Players of Sunitinib
Figure Docetaxel Figures
Table Key Players of Docetaxel
Figure Mitomycin Figures
Table Key Players of Mitomycin
Figure Fluorouracil Figures
Table Key Players of Fluorouracil
Figure Imatinib Figures
Table Key Players of Imatinib
Figure Trastuzumab Figures
Table Key Players of Trastuzumab
Table Global Gastric Cancer Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Gastric Cancer Drugs Report Years Considered
Table Global Gastric Cancer Drugs Market Size 2014-2025 (Million US$)
Figure Global Gastric Cancer Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gastric Cancer Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Gastric Cancer Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Gastric Cancer Drugs Market Share by Regions 2014-2019
Figure Global Gastric Cancer Drugs Market Share by Regions 2014-2019
Figure Global Gastric Cancer Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Gastric Cancer Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gastric Cancer Drugs Market Share by Manufacturers (2014-2019)
Figure Global Gastric Cancer Drugs Market Share by Manufacturers in 2018
Table Global Gastric Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gastric Cancer Drugs Product/Solution/Service
Table Date of Enter into Gastric Cancer Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gastric Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Gastric Cancer Drugs Market Size Share by Type (2014-2019)
Figure Global Gastric Cancer Drugs Market Size Market Share by Type (2014-2019)
Table Global Gastric Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Gastric Cancer Drugs Market Size Share by Application (2014-2019)
Figure Global Gastric Cancer Drugs Market Size Market Share by Application (2014-2019)
Figure Global Gastric Cancer Drugs Revenue Market Share by Application in 2018
Figure United States Gastric Cancer Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Gastric Cancer Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Gastric Cancer Drugs Market Share (2018-2019)
Table United States Gastric Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Gastric Cancer Drugs Market Share by Type (2014-2019)
Table United States Gastric Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Gastric Cancer Drugs Market Share by Application (2014-2019)
Figure Europe Gastric Cancer Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Gastric Cancer Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Gastric Cancer Drugs Market Share (2018-2019)
Table Europe Gastric Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Gastric Cancer Drugs Market Share by Type (2014-2019)
Table Europe Gastric Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Gastric Cancer Drugs Market Share by Application (2014-2019)
Figure China Gastric Cancer Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Gastric Cancer Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Gastric Cancer Drugs Market Share (2018-2019)
Table China Gastric Cancer Drugs Market Size by Type (2014-20189) (Million US$)
Table China Gastric Cancer Drugs Market Share by Type (2014-2019)
Table China Gastric Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table China Gastric Cancer Drugs Market Share by Application (2014-2019)
Figure Japan Gastric Cancer Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Gastric Cancer Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Gastric Cancer Drugs Market Share (2018-2019)
Table Japan Gastric Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Gastric Cancer Drugs Market Share by Type (2014-2019)
Table Japan Gastric Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Gastric Cancer Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Gastric Cancer Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gastric Cancer Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gastric Cancer Drugs Market Share (2018-2019)
Table Southeast Asia Gastric Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gastric Cancer Drugs Market Share by Type (2014-2019)
Table Southeast Asia Gastric Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gastric Cancer Drugs Market Share by Application (2014-2019)
Figure India Gastric Cancer Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Gastric Cancer Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Gastric Cancer Drugs Market Share (2018-2019)
Table India Gastric Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table India Gastric Cancer Drugs Market Share by Type (2014-2019)
Table India Gastric Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table India Gastric Cancer Drugs Market Share by Application (2014-2019)
Figure Central & South America Gastric Cancer Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gastric Cancer Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gastric Cancer Drugs Market Share (2018-2019)
Table Central & South America Gastric Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gastric Cancer Drugs Market Share by Type (2014-2019)
Table Central & South America Gastric Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gastric Cancer Drugs Market Share by Application (2014-2019)
Table Sanofi Company Details
Table Sanofi Revenue in Gastric Cancer Drugs Business (2014-2019) (Million US$)
Figure Sanofi Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Otsuka Pharmaceutical Company Details
Table Otsuka Pharmaceutical Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure Otsuka Pharmaceutical Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table Otsuka Pharmaceutical Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table Novartis Recent Development
Table Amgen Company Details
Table Amgen Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table Amgen Recent Development
Table Merck Company Details
Table Merck Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table Merck Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Daiichi-Sankyo Company Details
Table Daiichi-Sankyo Revenue in Gastric Cancer Drugs Business (2014-2019)(Million US$)
Figure Daiichi-Sankyo Revenue Growth Rate in Gastric Cancer Drugs Business (2014-2019)
Table Daiichi-Sankyo Recent Development
Table Bayer HealthCare Company Details
Table Global Gastric Cancer Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Gastric Cancer Drugs Market Size Share by Regions (2019-2025)
Figure Global Gastric Cancer Drugs Market Size Share by Regions in 2025
Figure United States Gastric Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gastric Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Gastric Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gastric Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gastric Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Gastric Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gastric Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Gastric Cancer Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Gastric Cancer Drugs Market Size by Product (2019-2025)
Figure Global Gastric Cancer Drugs Market Size by Product in 2025
Table Global Gastric Cancer Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Gastric Cancer Drugs Market Size by Application (2019-2025)
Figure Global Gastric Cancer Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---